Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.benzinga.com/general/biotech/23/04/31785092/alzheimers-disease-largely-remains-a-mystery-with-a-lack-of-highly-effective-treatments-could-reg
0
0
Alzheimer's Disease Largely Remains A Mystery, With A Lack Of Highly Effective Treatments — Could Regulatory T-Cells (Tregs) Be The Answer? - Eli Lilly (NYSE:LLY), Coya Therapeutics (NASDAQ:COYA) - Benzinga
4/13/23 at 11:59am
Organization
Benzinga
Author
David Willey
Details
71 words
Summarize
Neurological Conditions
Aging & Geriatrics
Health
form
Alzheimer's Disease Largely Remains A Mystery
T-Cells
iTreg
COYA
Coya Therapeutics
Nasdaq
Eli Lilly
NYSE
In many ways, Alzheimer's disease (AD) remains a mystery. Most common in those over 65, AD is the most common form of dementia, but its exact causes remain unclear, and treatments are unable to halt or reverse disease progression.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...